Literature DB >> 12163988

Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter.

Daniel J Müller1, T G Schulze, F Macciardi, S Ohlraun, M M Gross, H Scherk, H Neidt, Y V Syagailo, M Grässle, M M Nöthen, W Maier, K-P Lesch, M Rietschel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163988     DOI: 10.1055/s-2002-33199

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


× No keyword cloud information.
  6 in total

Review 1.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

Review 2.  The promise and reality of pharmacogenetics in psychiatry.

Authors:  Peter P Zandi; Jennifer T Judy
Journal:  Psychiatr Clin North Am       Date:  2010-03

3.  Pharmacoepigenetics of depression: no major influence of MAO-A DNA methylation on treatment response.

Authors:  Katharina Domschke; Nicola Tidow; Kathrin Schwarte; Christiane Ziegler; Klaus-Peter Lesch; Jürgen Deckert; Volker Arolt; Peter Zwanzger; Bernhard T Baune
Journal:  J Neural Transm (Vienna)       Date:  2014-05-10       Impact factor: 3.575

Review 4.  From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment.

Authors:  Chiara Fabbri; Stefano Porcelli; Alessandro Serretti
Journal:  Can J Psychiatry       Date:  2014-02       Impact factor: 4.356

5.  Pharmacogenetics of antidepressants.

Authors:  Concetta Crisafulli; Chiara Fabbri; Stefano Porcelli; Antonio Drago; Edoardo Spina; Diana De Ronchi; Alessandro Serretti
Journal:  Front Pharmacol       Date:  2011-02-16       Impact factor: 5.810

Review 6.  Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder.

Authors:  George I Papakostas; Maurizio Fava
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.